Bacterial vaginosis: More question than answers

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 5, 2004, Pages 448-

  Weir, Erica ^a  

^a Frontenac Lennox Addington Hlth U   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; GARDNERELLA VAGINALIS; GYNECOLOGY; HEALTH SURVEY; HUMAN; INFECTION RATE; INFECTION RISK; MEDICAL SOCIETY; MOBILUNCUS; MYCOPLASMA HOMINIS; PH MEASUREMENT; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PREVOTELLA; RISK REDUCTION; SHORT SURVEY; STATISTICAL SIGNIFICANCE; UREAPLASMA UREALYTICUM; VAGINA DISCHARGE; VAGINITIS; FEMALE; REVIEW;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; PREVALENCE; VAGINOSIS, BACTERIAL;

EID: 19444382149     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1041174     Document Type: Short Survey

References (3)

1. Koumans EH, Kendrick JS; CDC Bacterial Vaginosis Working Group. Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. Sex Transm Dis 2001;28:292-7.
2. Sweet R. Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol 2000;8:184-90.
3. McDonald H, Brocklehurst P, Parsons J, Vigneswaran R. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2003(2):CD000262.